For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Foghorn Therapeutics Inc.

USPTO Granted Patents = 17

EPO Patents = 1

Trademarks = 3

Forward Citations = 42

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Sabine K Ruppel (8 out of 10 patents)

Jason T Lowe (8 out of 10 patents)

Zhaoxia Yang (8 out of 8 patents)

4. Johannes H Voigt (7 out of 9 patents)

5. Rishi G Vaswani (6 out of 23 patents)

6. Shawn E R Schiller (5 out of 29 patents)

7. David Simon Millan (4 out of 4 patents)

8. Matthew Russell Netherton (4 out of 4 patents)

9. Francois Brucelle (4 out of 4 patents)

10. Neville J Anthony (3 out of 69 patents)

11. David S Huang (3 out of 4 patents)

12. Matthew Netherton (3 out of 3 patents)

13. Solymar Negretti (2 out of 2 patents)

14. Kevin J Wilson (2 out of 2 patents)

15. Chong-Hui Gu (1 out of 19 patents)

17 patents: Sort by Forward Citations

1. 12509453 - BRM/BRG1 inhibitors and uses thereof (2025-12-30),

2. 12486262 - Compounds and uses thereof (2025-12-02),

3. 12441726 - Compounds and uses thereof (2025-10-14),

4. 12391686 - Compounds and uses thereof (2025-08-19),

5. 12384776 - Compounds and uses thereof (2025-08-12),

6. 12383560 - Compounds and uses thereof (2025-08-12),

7. 12383555 - Methods of treating cancers (2025-08-12),

8. 12351579 - Compounds and uses thereof (2025-07-08),

9. 12139487 - Compounds and uses thereof (2024-11-12),

10. 11851445 - Compounds and uses thereof (2023-12-26),

11. 11787800 - BRD9 degraders and uses thereof (2023-10-17),

12. 11773085 - Methods and compounds for treating disorders (2023-10-03),

13. 11767330 - Citrate salt, pharmaceutical compositions, and methods of making and using the same (2023-09-26),

14. 11560381 - Compounds and uses thereof (2023-01-24),

15. 11497752 - Compounds and uses thereof (2022-11-15),

Foghorn Therapeutics is a biotechnology company focused on discovering and developing novel therapeutics that target chromatin remodeling complexes to treat cancer and other serious diseases. The company's unique approach combines cutting-edge science with deep expertise in chromatin biology to identify new drug targets and develop innovative therapies. With a team of world-class scientists and strategic partnerships, Foghorn Therapeutics is dedicated to advancing precision medicine for patients in need.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#129 in Cambridge, MA

#1,106 in Massachusetts

#18,331 in US

#34,856 in the World

Cambridge, MA, United States of America

Foghorn Therapeutics Inc.

Forward Citations = 42

26 inventors:

Sabine K Ruppel (8 out of 10 patents)

Jason T Lowe (8 out of 10 patents)

Zhaoxia Yang (8 out of 8 patents)

4. Johannes H Voigt (7 out of 9 patents)

5. Rishi G Vaswani (6 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…